8 February 2016

SQS win 22m worth of orders

18/08/11 Ben Jaglom

German software testing concern SQS Software Quality Systems (SQS) has announced a raft of contract wins worth a total of 22 million.

The AIM-quoted concern declared the contract wins will be coming with a deal to provide 'test management, automation and functional testing' to a 'large European logistics company' This contract is said to be worth 10 million over the next two years. Another deal is to provide the same services but to the French operations of a 'global insurance provider' worth 5 million. Its other contracts include wins with 'four leading retail companies' worth a total of 3.3 million, three public sector contracts worth 2.5 million, a contract with a 'multi-national media company' worth 500,000 and a deal with a 'major UK utilities company' costing €300,000.

SQS' chief executive officer Rudolf van Megen enthused that the win 'highlight the compelling value propositions' of SQS' products and services adding that it provides the company with confidence for the expansion of our regional presence and market share.'

Analysts at house broker Arbuthnot held their forecasts. The broker expects pre-tax profits of 11.4 million (EPS: 28.96 cents) on sales of 178.7 million for the year to December 2011. In 2012 it predicts profits of 13.6 million (EPS: 33.6 cents) on revenue of 199.6 million.

Growth Company Investor recommended shares in SQS this January as a buy/hold at 225p and they have since lost 11.3 per cent, currently trading at 199.5p. Though the latest wins have not moved forecasts they are nonetheless encouraging steps. We retain our buy/hold rating.

Tags: Business in Germany, German Technology, Independent software testing, Quality management services

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Forbidden focuses on selling 05/02/16

Forbidden Technologies (AIM: FBT) has been around a long time but has failed to generate much in the way of revenues, despite having a product that sounds like it should be a winner. There were board changes last year and new CEO Aziz Musa is shifting resources towards selling and away from technological development. This has to be the right strategy and we should find out if it’s working as this year unfolds.

Wash those nits right out of your hair! 04/02/16

Tyratech (AIM: TYRU) offers a compelling product proposition. Controlling bugs and parasites using conventional pesticides is both harmful to the environment and ineffective. Over the years insects have built up resistance to many of the chemicals used to kill them. So Tyratech’s natural products are not only safer but also a lot more effective than the competition. 

Angling for a cancer breakthrough 01/02/16

Results from medical device manufacturer Angle (AIM: AGL) showed its innovative Parsortix system to be nicely on track. The first commercial sales for research use have just been made and three leading cancer centres are moving forward with trials that will support its clinical use in the diagnosis of ovarian cancer.

2016 Quoted Company Award Winners announced 29/01/16

The 12th annual Grant Thornton Quoted Company Awards took place this week at the Natural History Museum in London. This prestigious event is organised by Growth Company Investor and is a celebration of the success and achievements of the UK’s smaller company sector. We published the shortlisted nominees for each award category earlier in January; so read on to see who the winners were...

Plexus hammered by oil industry shutdown 25/01/16

In the middle of 2014 Plexus (AIM: POS) was riding high with a share price of 320p giving the company a market value of £270 million. Today’s profit warning has seen the shares slump 40 per cent to just 73p, valuing Plexus at a mere £65 million. As an engineering company selling mainly into the oil industry, we shouldn’t be too surprised by downgrades. But the severity is startling.

Fusionex shares plunge on hidden profit warning 21/01/16

Malaysian big data software specialist Fusionex (AIM: FXI) has released an upbeat results statement for the year to September. As well as beating historic forecasts, the new financial year is said to have started “on a very strong note… the outlook for 2016 and beyond is very positive”. Sounds fantastic! Yet by this afternoon the shares had collapsed by 35 per cent.

More News